Skip to content
Trial Eligibility
Menu

rTMS for Incontinence After Prostate Treatment

NCT07948330

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Incontinence after prostate treatment (IPT) affects up to 25% of men following radical prostatectomy or other prostate therapies, primarily resulting from sphincteric weakness and impaired neuromuscular control. Current management options, including behavioral therapy and surgical implants, are often limited by modest effectiveness or invasiveness. Emerging neuroimaging evidence demonstrates that the pelvic supplementary motor area (pSMA) in the brain plays a critical regulatory role in controlling pelvic floor muscles and urethral sphincter activity.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Urinary Incontinence
  • Prostate Treatment
  • Incontinence After Prostate Treatment

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 to 80 years
Sex
Male
Healthy volunteers
Accepted
Sponsor
The Methodist Hospital Research Institute
Last updated on ClinicalTrials.gov
November 19, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • Houston Methodist Hospital · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.